Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

J.C. Kasius, J.M.A. Pijnenborg, K. Lindemann, D. Forsse, J. van Zwol, G.B. Kristensen, C. Krakstad, H.M.J. Werner, F. Amant*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Article number5848
Number of pages19
JournalCancers
Volume13
Issue number22
DOIs
Publication statusPublished - 1 Nov 2021

Keywords

  • endometrial cancer
  • uterine neoplasm
  • surgical staging
  • FIGO stage
  • molecular classification
  • TCGA
  • ProMisE
  • TRANSPORTEC
  • LYMPH-NODE METASTASIS
  • CIRCULATING TUMOR-CELLS
  • PHASE-III TRIAL
  • PERITONEAL CYTOLOGY
  • INTEROBSERVER VARIABILITY
  • PROSPECTIVE MULTICENTER
  • PROGNOSTIC-SIGNIFICANCE
  • ADJUVANT CHEMOTHERAPY
  • HIGH-INTERMEDIATE
  • ASTEC TRIAL

Cite this